Metraipolis › archive › dc_7e6a88cebd70
ctDNA Detected after Neoadjuvant Therapy for HER2-Positive Breast Cancer Is Associated with Inferior Outcomes and May Inform Adjuvant Therapy — Europe PMC PMID:41543393
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41543393
- DOI
- 10.1158/2767-9764.crc-24-0234
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T05:41:32.559Z
- SHA-256 of the archived text
718a4de5d2ea74a4f4621df679ccc37759b876f93e0160ddc8c765b5275fd9b4- Stable URL of this page
https://metraipolis.com/documento/dc_7e6a88cebd70
How to cite
ctDNA Detected after Neoadjuvant Therapy for HER2-Positive Breast Cancer Is Associated with Inferior Outcomes and May Inform Adjuvant Therapy — Europe PMC PMID:41543393 — Europe PMC (en), https://europepmc.org/article/MED/41543393 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e6a88cebd70 (Metraipolis archive dc_7e6a88cebd70, sha256 718a4de5d2ea74a4f4621df679ccc37759b876f93e0160ddc8c765b5275fd9b4)
BibTeX
@misc{dc7e6a88cebd70,
title = {ctDNA Detected after Neoadjuvant Therapy for HER2-Positive Breast Cancer Is Associated with Inferior Outcomes and May Inform Adjuvant Therapy — Europe PMC PMID:41543393},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41543393},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e6a88cebd70; sha256 718a4de5d2ea74a4f4621df679ccc37759b876f93e0160ddc8c765b5275fd9b4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41543393. Agents can read the archived copy with the MCP tool read_document.